Tidal Investments LLC Has $26.98 Million Stock Position in HCA Healthcare, Inc. $HCA

Tidal Investments LLC increased its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 12.3% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 69,190 shares of the company’s stock after purchasing an additional 7,570 shares during the period. Tidal Investments LLC’s holdings in HCA Healthcare were worth $26,976,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of HCA. Archford Capital Strategies LLC lifted its position in shares of HCA Healthcare by 8.0% in the second quarter. Archford Capital Strategies LLC now owns 2,943 shares of the company’s stock worth $1,147,000 after purchasing an additional 217 shares in the last quarter. National Pension Service boosted its position in HCA Healthcare by 0.5% during the second quarter. National Pension Service now owns 591,578 shares of the company’s stock valued at $230,650,000 after purchasing an additional 2,820 shares during the last quarter. Darsana Capital Partners LP grew its stake in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after buying an additional 350,000 shares in the last quarter. Cidel Asset Management Inc. raised its holdings in shares of HCA Healthcare by 8.0% during the 2nd quarter. Cidel Asset Management Inc. now owns 1,585 shares of the company’s stock valued at $618,000 after purchasing an additional 118 shares in the last quarter. Finally, Capital Analysts LLC lifted its holdings in HCA Healthcare by 10.3% in the 2nd quarter. Capital Analysts LLC now owns 642 shares of the company’s stock worth $250,000 after purchasing an additional 60 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA opened at $422.47 on Thursday. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The company has a fifty day moving average price of $404.41 and a two-hundred day moving average price of $434.23. The firm has a market capitalization of $91.47 billion, a PE ratio of 14.14, a P/E/G ratio of 1.32 and a beta of 1.10.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter last year, the business earned $6.84 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. Equities analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. TD Cowen lowered their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. UBS Group decreased their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Cantor Fitzgerald cut their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. The Goldman Sachs Group lowered their price target on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research note on Thursday, August 20th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $462.64.

Read Our Latest Stock Report on HCA Healthcare

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.